Science for a better life

Investor News

1 - 10

11 - 20

21 - 30

31 - 40

August 20, 2019

Bayer to sell its Animal Health business unit to Elanco for 7.6 billion U.S. dollars

more

August 08, 2019

Bayer acquires BlueRock Therapeutics to build leading position in cell therapy

more

August 06, 2019

Bayer and LANXESS to sell their stakes in Currenta to Macquarie Infrastructure and Real Assets

more

July 31, 2019

Not intended for U.S. and UK Media

U.S. FDA approves darolutamide, a new treatment for men with non-metastatic castration-resistant prostate cancer

more

July 30, 2019

Second quarter of 2019:

Bayer on track in operational business

more

July 26, 2019

Not intended for U.S. and UK Media

Bayer receives positive CHMP opinion for precision oncology treatment larotrectinib with first ever tumor-agnostic indication in in Europe

more

July 22, 2019

Yellow Wood Partners to acquire iconic Dr. Scholl's™ brand from Bayer

more

July 18, 2019

Not intended for U.S. and UK Media

Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter into a clinical collaboration agreement to investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as combination therapy in patients with colorectal cancer

more

July 08, 2019

Not intended for U.S. and UK Media - Important step towards improved treatment for children with venous thromboembolism

Rivaroxaban demonstrates strong efficacy and safety profile in phase III study in children with thromboembolism

more

July 02, 2019

LEO Pharma completes the acquisition of Bayer's prescription dermatology business

more

1 - 10

11 - 20

21 - 30

31 - 40

Previous News can be found in the Archive

Services

Current Event

August 27, 2019

Commerzbank Sector Conference, Frankfurt, Germany

Current Links

IR News Archive Overview

Download Acrobat Reader

Email Newsletter

Last updated: February 15, 2019